JP2018529649A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529649A5
JP2018529649A5 JP2018507019A JP2018507019A JP2018529649A5 JP 2018529649 A5 JP2018529649 A5 JP 2018529649A5 JP 2018507019 A JP2018507019 A JP 2018507019A JP 2018507019 A JP2018507019 A JP 2018507019A JP 2018529649 A5 JP2018529649 A5 JP 2018529649A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
heterocyclyl
hydrogen
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018507019A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529649A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/046889 external-priority patent/WO2017027841A1/en
Publication of JP2018529649A publication Critical patent/JP2018529649A/ja
Publication of JP2018529649A5 publication Critical patent/JP2018529649A5/ja
Pending legal-status Critical Current

Links

JP2018507019A 2015-08-12 2016-08-12 フェニルスルホンアミド−ベンゾフラン誘導体およびその使用 Pending JP2018529649A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562204385P 2015-08-12 2015-08-12
US62/204,385 2015-08-12
US201562253030P 2015-11-09 2015-11-09
US62/253,030 2015-11-09
PCT/US2016/046889 WO2017027841A1 (en) 2015-08-12 2016-08-12 Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases

Publications (2)

Publication Number Publication Date
JP2018529649A JP2018529649A (ja) 2018-10-11
JP2018529649A5 true JP2018529649A5 (enExample) 2019-09-26

Family

ID=56740558

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018507019A Pending JP2018529649A (ja) 2015-08-12 2016-08-12 フェニルスルホンアミド−ベンゾフラン誘導体およびその使用

Country Status (7)

Country Link
US (2) US10975051B2 (enExample)
EP (1) EP3334713B1 (enExample)
JP (1) JP2018529649A (enExample)
CN (1) CN108349924A (enExample)
AU (2) AU2016306694B2 (enExample)
CA (1) CA2990477A1 (enExample)
WO (2) WO2017027841A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027841A1 (en) 2015-08-12 2017-02-16 Memorial Sloan-Kettering Cancer Center Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases
WO2017087810A1 (en) * 2015-11-20 2017-05-26 Memorial Sloan-Kettering Cancer Center Method for screening inhibitors targeting anti-apoptotic survival pathways
JP2019103077A (ja) * 2017-12-07 2019-06-24 Kddi株式会社 管理装置、管理方法、管理プログラム及び通信システム
CN111904958B (zh) * 2019-05-09 2022-09-13 浙江大学 Umi-77作为线粒体自噬诱导剂在制备治疗炎症及神经退行性疾病药物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (fr) 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
EP1161444A4 (en) * 1999-02-26 2005-11-02 Univ Johns Hopkins A novel inhibitor of programmed cell death
AR031130A1 (es) 2000-09-20 2003-09-10 Abbott Lab N-acilsulfonamidas promotoras de la apoptosis
NZ529792A (en) 2001-05-30 2007-04-27 Univ Michigan Small molecule antagonists of Bcl-2 family proteins
WO2003038060A2 (en) 2001-11-01 2003-05-08 The Regents Of The University Of Michigan Small molecule inhibitors targeted at bcl-2
US20050085420A1 (en) * 2003-07-22 2005-04-21 Stanley Korsmeyer Method of modulating apoptosis and compositions thereof
WO2008017123A1 (en) 2006-08-11 2008-02-14 The Walter And Eliza Hall Institute Of Medical Research Methods for modulating apoptosis in platelets
EP3124494B1 (en) * 2008-12-09 2019-06-19 Dana-Farber Cancer Institute, Inc. Methods and compositions for specific modulation of mcl-1
EA020586B1 (ru) * 2009-09-10 2014-12-30 Новартис Аг СУЛЬФОНАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ БЕЛКОВ СЕМЕЙСТВА Bcl-2, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ЛЕЧЕНИЯ РАКА
US8501811B2 (en) 2010-06-17 2013-08-06 Washington University TASPASE1 inhibitors and their uses
FR2962649B1 (fr) 2010-07-19 2025-10-24 Conservatoire Nat Arts Et Metiers Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
EP2619184B1 (en) 2010-09-24 2018-05-23 The Regents of the University of Michigan Deubiquitinase inhibitors and methods for use of the same
US20140296223A1 (en) 2011-09-01 2014-10-02 The General Hospital Corporation Method for regulating skin pigmentation
US9744171B2 (en) 2012-03-06 2017-08-29 Vanderbilt University Positive allosteric modulators for melanocortin receptors
US10093640B2 (en) 2012-09-21 2018-10-09 Vanderbilt University Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
WO2014109696A1 (en) 2013-01-10 2014-07-17 Alf Grandien Method for immortalization of b cells and uses thereof
WO2017027841A1 (en) * 2015-08-12 2017-02-16 Memorial Sloan-Kettering Cancer Center Phenylsulfonamido-benzofuran derivatives and uses thereof in the treatment of proliferative diseases
WO2017087810A1 (en) 2015-11-20 2017-05-26 Memorial Sloan-Kettering Cancer Center Method for screening inhibitors targeting anti-apoptotic survival pathways

Similar Documents

Publication Publication Date Title
JP2014511892A5 (enExample)
JP2014511891A5 (enExample)
JP2016534063A5 (enExample)
JP2015508103A5 (enExample)
JP2017537940A5 (enExample)
JP2015520769A5 (enExample)
JP2017504635A5 (enExample)
JP2015024998A5 (enExample)
JP2016506962A5 (enExample)
JP2017526677A5 (enExample)
JP2010526814A5 (enExample)
JP2016515561A5 (enExample)
JP2018518537A5 (enExample)
JP2016514159A5 (enExample)
JP2016516043A5 (enExample)
JP2013542261A5 (enExample)
JP2016503786A5 (enExample)
JP2014500861A5 (enExample)
JP2019500387A5 (enExample)
JP2018537535A5 (enExample)
JP2014508804A5 (enExample)
JP2014500265A5 (enExample)
JP2016531126A5 (enExample)
JP2018529649A5 (enExample)
JP2016522254A5 (enExample)